PharmaCyte Biotech (PMCB) Profit After Tax (2010 - 2026)
PharmaCyte Biotech (PMCB) posted Profit After Tax of -$840,430 for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$630,512 a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Profit After Tax (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jul 31, 2026, Profit After Tax at PharmaCyte Biotech was -$6.33 million; for FY2026 (ended Apr 30, 2026), it was -$6.12 million.
- In prior fiscal years, PharmaCyte Biotech's Profit After Tax was -$2.96 million in FY2025, -$5.12 million in FY2024, -$4.52 million in FY2023 and -$4.23 million in FY2022.
- Quarterly Profit After Tax has run from a low of -$2.43 million in fiscal Q4 2026 to a high of -$180,346 in fiscal Q4 2023 over five years.
- According to Business Quant data, Profit After Tax for the three prior fiscal quarters was -$2.43 million (Q4 2026), -$1.89 million (Q3 2026) and -$1.17 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | -840,430.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -840,430.00 |
| Apr 30, 2026 | -2.43 Mn |
| Jan 31, 2026 | -1.89 Mn |
| Oct 31, 2025 | -1.17 Mn |
| Jul 31, 2025 | -630,512.00 |
| Apr 30, 2025 | -811,989.00 |
| Jan 31, 2025 | -704,560.00 |
| Oct 31, 2024 | -723,498.00 |
| Jul 31, 2024 | -721,455.00 |
| Apr 30, 2024 | -2.42 Mn |
| Jan 31, 2024 | -987,284.00 |
| Oct 31, 2023 | -515,339.00 |
| Jul 31, 2023 | -1.20 Mn |
| Apr 30, 2023 | -180,346.00 |
| Jan 31, 2023 | -917,094.00 |
| Oct 31, 2022 | -1.88 Mn |
| Jul 31, 2022 | -1.54 Mn |
| Apr 30, 2022 | -1.42 Mn |
| Jan 31, 2022 | -810,660.00 |
| Oct 31, 2021 | -979,266.00 |
API Access
PharmaCyte Biotech Profit After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();